Internal Reference Number: FOI_8635
Date Request Received: 09/05/2025 00:00:00
Date Request Replied To: 20/05/2025 00:00:00
This response was sent via: By Email
Request Summary: Request on intra-vitreal injections or implants
Request Category: Researcher
Question Number 1: How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2025: • Aflibercept • Bevacizumab • Brolucizumab • Dexamethasone • Faricimab • Fluocinolone acetonide • Ranibizumab - Lucentis • Ranibizumab - Biosimilar (Ongavia, Ximluci, Byooviz, Rimmyrah) | |
Answer To Question 1: • Aflibercept 1205 • Bevacizumab 8 • Brolucizumab 0 • Dexamethasone 7 • Faricimab 1019 • Fluocinolone acetonide 0 • Ranibizumab - Lucentis <5 • Ranibizumab - Biosimilar (Ongavia, Ximluci, Byooviz, Rimmyrah) 0 | |
Question Number 2: Please provide the number of injections/implants by eye condition for the four-month period from January to April 2025: (see attached) | |
Answer To Question 2: See attached. To accompany this answer to question 2 please also see the documents listed below: ![]() | |
Please see Attachments: | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.